Ethical issues related to animal biotechnologyKAUSHAL SAHU
Introduction
Why are genetically modified animals produced?
Examples of transgenic animals
Why are animals used instead of genetically modified microbes or plants?
Ethical issues
Religious concerns
Responsibility of Scientists
Need for Guidelines
Conclusion
References
The document discusses various applications of animal biotechnology including transgenic animals, biopharming, and stem cells. It provides details on using transgenic mice, livestock, fish, and other animals to produce pharmaceuticals like growth factors, hormones, and clotting factors. Stem cells are discussed for their role in disease treatment, drug testing, and therapeutic cloning applications.
Ethical issues related to transgenic animalsmahathiviji
This document discusses the ethical issues related to transgenic animals. It begins by defining ethics, bioethics, and the two types of genetic modification - altering genes normally present or transferring genes between individuals. Genetic modification of animals is used to help research human diseases, develop new drugs, provide transplant tissues/organs, and enhance livestock. However, this raises ethical concerns like unpredictable ecosystem impacts, animal welfare issues, risks to human and environmental health, "playing God", and religious concerns over gene transfers between species. The document also discusses regulation bodies like GEAC and issues around patents and biopiracy of genetically modified organisms.
This document discusses various methods for transferring genes into animal cells, including viral and non-viral approaches. Viral methods use viruses like adenovirus to transfer genes, while non-viral methods include biochemical techniques like calcium phosphate transfection, lipid-mediated transfection using lipofectamine, and physical methods like microinjection, particle bombardment/gene guns, ultrasound, and electroporation. The document provides detailed protocols for lipid-mediated transfection and some of the other non-viral methods.
Transgenic animals are produced by inserting foreign genes into their genomes using recombinant DNA methodology. This allows for increased growth, improved disease resistance, and other benefits. However, it can also lead to unintended effects if the inserted gene has multiple functions or causes mutations. Common methods to create transgenic animals include embryonic stem cell methods, pronuclear injection, and retrovirus-mediated gene transfer. Examples include transgenic mice, cows, fish, sheep, and monkeys.
Transgenesis involves introducing foreign DNA into an animal's genome. This allows for the production of transgenic animals that exhibit new traits. Common methods for creating transgenic animals include pronuclear microinjection, embryonic stem cell manipulation, and retrovirus-mediated gene transfer. Examples of transgenic animals include glowing fish, disease models like Alzheimer's mice, and farm animals engineered for increased wool/milk. While transgenic technology has benefits for research, agriculture, and medicine, it also carries some risks that require further study.
Transfection involves introducing foreign DNA into host cells to produce a new phenotype. There are two main methods of transfection - vector-mediated and non-vector mediated. Vector-mediated transfection uses bacteriophage, retroviral, cosmid, baculovirus, and plasmid vectors to introduce DNA. Non-vector mediated methods include direct techniques like microinjection, electroporation, and particle bombardment, and indirect techniques like calcium phosphate precipitation and DEAE-dextran. Retroviral vectors are modified retroviruses that can introduce foreign DNA into host chromosomal DNA. Microinjection involves injecting DNA directly into cells using a micropipette under a microscope. Electroporation uses electric pulses to create temporary
Ethical issues related to animal biotechnologyKAUSHAL SAHU
Introduction
Why are genetically modified animals produced?
Examples of transgenic animals
Why are animals used instead of genetically modified microbes or plants?
Ethical issues
Religious concerns
Responsibility of Scientists
Need for Guidelines
Conclusion
References
The document discusses various applications of animal biotechnology including transgenic animals, biopharming, and stem cells. It provides details on using transgenic mice, livestock, fish, and other animals to produce pharmaceuticals like growth factors, hormones, and clotting factors. Stem cells are discussed for their role in disease treatment, drug testing, and therapeutic cloning applications.
Ethical issues related to transgenic animalsmahathiviji
This document discusses the ethical issues related to transgenic animals. It begins by defining ethics, bioethics, and the two types of genetic modification - altering genes normally present or transferring genes between individuals. Genetic modification of animals is used to help research human diseases, develop new drugs, provide transplant tissues/organs, and enhance livestock. However, this raises ethical concerns like unpredictable ecosystem impacts, animal welfare issues, risks to human and environmental health, "playing God", and religious concerns over gene transfers between species. The document also discusses regulation bodies like GEAC and issues around patents and biopiracy of genetically modified organisms.
This document discusses various methods for transferring genes into animal cells, including viral and non-viral approaches. Viral methods use viruses like adenovirus to transfer genes, while non-viral methods include biochemical techniques like calcium phosphate transfection, lipid-mediated transfection using lipofectamine, and physical methods like microinjection, particle bombardment/gene guns, ultrasound, and electroporation. The document provides detailed protocols for lipid-mediated transfection and some of the other non-viral methods.
Transgenic animals are produced by inserting foreign genes into their genomes using recombinant DNA methodology. This allows for increased growth, improved disease resistance, and other benefits. However, it can also lead to unintended effects if the inserted gene has multiple functions or causes mutations. Common methods to create transgenic animals include embryonic stem cell methods, pronuclear injection, and retrovirus-mediated gene transfer. Examples include transgenic mice, cows, fish, sheep, and monkeys.
Transgenesis involves introducing foreign DNA into an animal's genome. This allows for the production of transgenic animals that exhibit new traits. Common methods for creating transgenic animals include pronuclear microinjection, embryonic stem cell manipulation, and retrovirus-mediated gene transfer. Examples of transgenic animals include glowing fish, disease models like Alzheimer's mice, and farm animals engineered for increased wool/milk. While transgenic technology has benefits for research, agriculture, and medicine, it also carries some risks that require further study.
Transfection involves introducing foreign DNA into host cells to produce a new phenotype. There are two main methods of transfection - vector-mediated and non-vector mediated. Vector-mediated transfection uses bacteriophage, retroviral, cosmid, baculovirus, and plasmid vectors to introduce DNA. Non-vector mediated methods include direct techniques like microinjection, electroporation, and particle bombardment, and indirect techniques like calcium phosphate precipitation and DEAE-dextran. Retroviral vectors are modified retroviruses that can introduce foreign DNA into host chromosomal DNA. Microinjection involves injecting DNA directly into cells using a micropipette under a microscope. Electroporation uses electric pulses to create temporary
The document discusses several ethical issues related to animal biotechnology. It covers three main categories of ethical issues: 1) Impacts on animal welfare, 2) Governance of research institutions, and 3) Relationship between humans and animals. Specific topics discussed include genetic modification, religious concerns, animal welfare as defined by the five freedoms, environmental effects, concerns about unintended consequences for animal health, and arguments around risks and benefits. Extrinsic concerns are also addressed, such as potential abuse of the technology and predicting future impacts.
Animal biotechnology is the use of science and engineering to modify living organisms, with the goals of making products, improving animals, and developing microorganisms for agricultural uses. Examples include creating transgenic animals through gene knock out or knock in technology. Round Oak Rag Apple, an influential dairy cow born in 1965, had over 80,000 daughters who produced a total of 53.1 billion kg of milk in 1944, which increased to 84.2 billion kg in 1997 due to genetic improvement through artificial insemination. Common animal biotechnologies include artificial insemination, progesterone monitoring, estrus synchronization, in vitro fertilization/embryo transfer, molecular markers, cryopreservation, semen and embryo sexing, cloning,
1. The history of biotechnology can be divided into 3 stages - ancient, classical, and modern. Ancient biotech involved early applications related to food and shelter. Classical biotech built on these techniques and promoted fermentation. Modern biotech manipulates genetic information through techniques like genetic engineering.
2. Biotechnology has 5 main branches - animal, medical, environmental, industrial, and plant. Animal biotech improves livestock through techniques like artificial insemination, cloning, and transgenic animals. Medical biotech develops drugs and treatments.
3. Environmental biotech applies bioprocesses to clean pollution through bioremediation. Industrial biotech uses organisms to produce chemicals. Plant biotech engineers crops for desired traits like pest
This document discusses xenotransplantation, which is the transplantation of cells, tissues, or organs from one species to another. It provides a brief history of xenotransplantation experiments dating back to the 17th century. Pigs and primates are commonly used as organ donors due to their similarities to human genetics. While xenotransplantation could help address the shortage of human organs, there are also health risks like transmitting diseases. The document examines specific cases where baboon bone marrow and human tumor cells were transplanted into other species and analyzes the results. It concludes by discussing the future potential of using biotechnology to reduce organ rejection and allow xenotransplantation to meet the growing demand for transplants.
8. ethical and social issues in animal biotechnologyMuhammadKhalid350
This document discusses the ethics of animal biotechnology. It defines ethics and explores intrinsic and extrinsic ethical concerns. Intrinsic concerns include views that biotechnology violates natural boundaries or divine order. Extrinsic concerns involve animal welfare, human and environmental health. The document examines ethical issues around specific applications like cloning, IVF and chimeras. It also discusses regulatory approaches like the precautionary principle.
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...Prasenjit Mitra
This set of slides gives an overview regarding the various omics technologies available and how they can be used for improvement in clinical setting or research
Expression of recombinant proteins in mammalian cell linesSandeep Kumar
The speaker discusses mammalian cell-based recombinant protein production. Mammalian cells like CHO cells are commonly used as they can properly fold and modify proteins, similar to human cells. Issues include mammalian cells being fragile, slow-growing, and techniques being expensive. Benefits are low immunogenicity and high safety due to not being susceptible to human pathogens.
Genomic databases are referred to as online repositories of genomic variants, described for a single (locus-specific) or more (general) genes or specifically for a population or ethnic group (national/ethnic).
This is about methods of creating transgenic animals,applications of transgenic animals in biotechnology and application of transgenic animals in pharmaceuticals.
This document summarizes a seminar presentation on ethical issues in biotechnology. It begins with an introduction to biotechnology and ethics. It then discusses some of the major ethical issues that arise in biotechnology, including socio-economic issues regarding public perception and awareness, cultural issues around modifying life itself, legal issues around new techniques like gene therapy and stem cells, environmental issues regarding impacts on the ecosystem, and religious issues around views of what is natural or against divine order. The conclusion calls for fully analyzing each biotechnology application scientifically and ethically to maximize benefits while acknowledging uncertainties and taking precautions.
This document discusses various applications of tissue culture, including intracellular studies, elucidation of intracellular processes, studies of cell-cell interactions, and evaluation of environmental interactions. It also notes that animal cell culture can be used to produce medically important proteins like interferon, blood clotting factors, and monoclonal antibodies. Major developments in cell culture technology included the use of antibiotics, trypsin to subculture cells, and chemically defined culture media. Common cell culture media include Eagle's Minimum Essential Medium, Dulbecco's Modified Eagle's Medium, and RPMI-1640.
This document discusses the production of recombinant therapeutic proteins. It outlines three main methods: microbial bioreactors like E. coli, mammalian cell culture bioreactors like CHO cells, and transgenic animal bioreactors. Transgenic animals are produced via DNA microinjection into embryos to incorporate expression vectors for target proteins. Their milk can then produce large quantities of complex proteins through scale-up. While advantageous for production scale, transgenic systems have limitations regarding animal health effects and post-translational modifications. Examples of therapeutic proteins produced include antithrombin in transgenic goats and alpha-1-antitrypsin in transgenic sheep.
GMO, Genetically modified organisms, agricultural and horticultural crops cur...jagathesan krishnasamy
A genetically modified organism is one whose genetic material has been altered using genetic engineering techniques. GMOs are commonly used in foods and medicines but have also led to concerns about potential dangers to human health and the environment. Key points made in the document include that GMOs are modified by eliminating, adding, or modifying specific genes, often from other organisms, and they are used in foods like soybeans, canola, and corn as well as in medicines. The history and growth of GMO usage is also discussed. Pros and criticisms of genetically modified foods are outlined regarding environmental, health, economic, and other issues.
The document discusses molecular farming, which involves using plants or other organisms to produce valuable proteins or pharmaceuticals. It provides a brief history of molecular farming beginning in 1986. It then discusses various host systems used, including bacteria, yeast, algae, plant cell cultures, transgenic plants, and whole plants or animals. The costs of production are much lower for plant systems compared to other methods. Key plant expression systems include transgenic plants, plant cell suspensions, transplastomic plants, transient expression systems, and hydroponic cultures. Many therapeutic proteins, industrial enzymes, antibodies, and vaccines have been produced in different plant host systems. Some early commercial products included avidin, beta-glucuronidase, and trypsin. Leading
1. Biopharming involves the production of therapeutic proteins through transgenic animals and offers advantages over conventional production methods like lower costs, higher yields, and proper post-translational modifications.
2. The mammary gland is often used for expression since milk can be easily collected and purified. Therapeutic proteins are commonly expressed at grams per liter of milk.
3. While biopharming has promise, challenges remain around low success rates, animal health issues, and concerns about transgene escape into the environment. Ongoing work aims to improve efficiency and safety.
The document discusses biobusiness and biosafety, providing definitions and opportunities for biotechnology in developing countries. It examines the market for biobusiness, key opportunity areas, and factors for successful bioenterprise innovation including focusing on high-value opportunities, recognizing that innovation need not have long life cycles, and emphasizing people over technologies. The document also outlines biosafety levels and concepts from containment to facility design to protect laboratory workers and the environment.
This presentation is for those who want to go in the field of BIOTECHNOLOGY.
All career related things are mentioned in this ppt.
Hope it helps you !!!
The document discusses several ethical issues related to animal biotechnology. It covers three main categories of ethical issues: 1) Impacts on animal welfare, 2) Governance of research institutions, and 3) Relationship between humans and animals. Specific topics discussed include genetic modification, religious concerns, animal welfare as defined by the five freedoms, environmental effects, concerns about unintended consequences for animal health, and arguments around risks and benefits. Extrinsic concerns are also addressed, such as potential abuse of the technology and predicting future impacts.
Animal biotechnology is the use of science and engineering to modify living organisms, with the goals of making products, improving animals, and developing microorganisms for agricultural uses. Examples include creating transgenic animals through gene knock out or knock in technology. Round Oak Rag Apple, an influential dairy cow born in 1965, had over 80,000 daughters who produced a total of 53.1 billion kg of milk in 1944, which increased to 84.2 billion kg in 1997 due to genetic improvement through artificial insemination. Common animal biotechnologies include artificial insemination, progesterone monitoring, estrus synchronization, in vitro fertilization/embryo transfer, molecular markers, cryopreservation, semen and embryo sexing, cloning,
1. The history of biotechnology can be divided into 3 stages - ancient, classical, and modern. Ancient biotech involved early applications related to food and shelter. Classical biotech built on these techniques and promoted fermentation. Modern biotech manipulates genetic information through techniques like genetic engineering.
2. Biotechnology has 5 main branches - animal, medical, environmental, industrial, and plant. Animal biotech improves livestock through techniques like artificial insemination, cloning, and transgenic animals. Medical biotech develops drugs and treatments.
3. Environmental biotech applies bioprocesses to clean pollution through bioremediation. Industrial biotech uses organisms to produce chemicals. Plant biotech engineers crops for desired traits like pest
This document discusses xenotransplantation, which is the transplantation of cells, tissues, or organs from one species to another. It provides a brief history of xenotransplantation experiments dating back to the 17th century. Pigs and primates are commonly used as organ donors due to their similarities to human genetics. While xenotransplantation could help address the shortage of human organs, there are also health risks like transmitting diseases. The document examines specific cases where baboon bone marrow and human tumor cells were transplanted into other species and analyzes the results. It concludes by discussing the future potential of using biotechnology to reduce organ rejection and allow xenotransplantation to meet the growing demand for transplants.
8. ethical and social issues in animal biotechnologyMuhammadKhalid350
This document discusses the ethics of animal biotechnology. It defines ethics and explores intrinsic and extrinsic ethical concerns. Intrinsic concerns include views that biotechnology violates natural boundaries or divine order. Extrinsic concerns involve animal welfare, human and environmental health. The document examines ethical issues around specific applications like cloning, IVF and chimeras. It also discusses regulatory approaches like the precautionary principle.
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...Prasenjit Mitra
This set of slides gives an overview regarding the various omics technologies available and how they can be used for improvement in clinical setting or research
Expression of recombinant proteins in mammalian cell linesSandeep Kumar
The speaker discusses mammalian cell-based recombinant protein production. Mammalian cells like CHO cells are commonly used as they can properly fold and modify proteins, similar to human cells. Issues include mammalian cells being fragile, slow-growing, and techniques being expensive. Benefits are low immunogenicity and high safety due to not being susceptible to human pathogens.
Genomic databases are referred to as online repositories of genomic variants, described for a single (locus-specific) or more (general) genes or specifically for a population or ethnic group (national/ethnic).
This is about methods of creating transgenic animals,applications of transgenic animals in biotechnology and application of transgenic animals in pharmaceuticals.
This document summarizes a seminar presentation on ethical issues in biotechnology. It begins with an introduction to biotechnology and ethics. It then discusses some of the major ethical issues that arise in biotechnology, including socio-economic issues regarding public perception and awareness, cultural issues around modifying life itself, legal issues around new techniques like gene therapy and stem cells, environmental issues regarding impacts on the ecosystem, and religious issues around views of what is natural or against divine order. The conclusion calls for fully analyzing each biotechnology application scientifically and ethically to maximize benefits while acknowledging uncertainties and taking precautions.
This document discusses various applications of tissue culture, including intracellular studies, elucidation of intracellular processes, studies of cell-cell interactions, and evaluation of environmental interactions. It also notes that animal cell culture can be used to produce medically important proteins like interferon, blood clotting factors, and monoclonal antibodies. Major developments in cell culture technology included the use of antibiotics, trypsin to subculture cells, and chemically defined culture media. Common cell culture media include Eagle's Minimum Essential Medium, Dulbecco's Modified Eagle's Medium, and RPMI-1640.
This document discusses the production of recombinant therapeutic proteins. It outlines three main methods: microbial bioreactors like E. coli, mammalian cell culture bioreactors like CHO cells, and transgenic animal bioreactors. Transgenic animals are produced via DNA microinjection into embryos to incorporate expression vectors for target proteins. Their milk can then produce large quantities of complex proteins through scale-up. While advantageous for production scale, transgenic systems have limitations regarding animal health effects and post-translational modifications. Examples of therapeutic proteins produced include antithrombin in transgenic goats and alpha-1-antitrypsin in transgenic sheep.
GMO, Genetically modified organisms, agricultural and horticultural crops cur...jagathesan krishnasamy
A genetically modified organism is one whose genetic material has been altered using genetic engineering techniques. GMOs are commonly used in foods and medicines but have also led to concerns about potential dangers to human health and the environment. Key points made in the document include that GMOs are modified by eliminating, adding, or modifying specific genes, often from other organisms, and they are used in foods like soybeans, canola, and corn as well as in medicines. The history and growth of GMO usage is also discussed. Pros and criticisms of genetically modified foods are outlined regarding environmental, health, economic, and other issues.
The document discusses molecular farming, which involves using plants or other organisms to produce valuable proteins or pharmaceuticals. It provides a brief history of molecular farming beginning in 1986. It then discusses various host systems used, including bacteria, yeast, algae, plant cell cultures, transgenic plants, and whole plants or animals. The costs of production are much lower for plant systems compared to other methods. Key plant expression systems include transgenic plants, plant cell suspensions, transplastomic plants, transient expression systems, and hydroponic cultures. Many therapeutic proteins, industrial enzymes, antibodies, and vaccines have been produced in different plant host systems. Some early commercial products included avidin, beta-glucuronidase, and trypsin. Leading
1. Biopharming involves the production of therapeutic proteins through transgenic animals and offers advantages over conventional production methods like lower costs, higher yields, and proper post-translational modifications.
2. The mammary gland is often used for expression since milk can be easily collected and purified. Therapeutic proteins are commonly expressed at grams per liter of milk.
3. While biopharming has promise, challenges remain around low success rates, animal health issues, and concerns about transgene escape into the environment. Ongoing work aims to improve efficiency and safety.
The document discusses biobusiness and biosafety, providing definitions and opportunities for biotechnology in developing countries. It examines the market for biobusiness, key opportunity areas, and factors for successful bioenterprise innovation including focusing on high-value opportunities, recognizing that innovation need not have long life cycles, and emphasizing people over technologies. The document also outlines biosafety levels and concepts from containment to facility design to protect laboratory workers and the environment.
This presentation is for those who want to go in the field of BIOTECHNOLOGY.
All career related things are mentioned in this ppt.
Hope it helps you !!!
This document provides information about mushroom cultivation. It begins by defining fungi and listing common types including mushrooms. It then discusses the nutritional value of mushrooms and lists some edible varieties. The bulk of the document describes the cultivation methodology, including selecting and preparing appropriate substrates like rice straw, sterilizing the substrates, filling bags and inoculating with spores, maintaining incubation conditions, and harvesting the mature mushrooms. Key steps involve sterilizing substrates to prevent contamination, maintaining proper humidity and darkness during incubation, and harvesting mushrooms when caps reach 8-10 cm in diameter. Precautions are also outlined like using quality substrates and properly sterilizing and packing materials.
A transgenic animal is one that has had foreign DNA inserted into its genome. The first transgenic animal was a mouse created in 1982 by inserting a human growth hormone gene. Transgenic animals are created through pronuclear microinjection or stem cell methods. They have applications in medicine, agriculture, and industry. However, some argue that transgenic technology raises ethical issues.
Gm os and social and ethical issues pptAdnya Desai
This document discusses GMOs and their social and ethical issues. It begins by defining genetic modified organisms and describing their uses, including for human gene therapy and producing transgenic plants. It then discusses social concerns about GMOs, including potential health risks to animals and humans from consuming GM foods, environmental risks, and issues around labeling and economics. Finally, it covers some ethical issues like biopiracy and ensuring compensation and benefit sharing between developed and developing nations regarding genetic resources and traditional knowledge.
Transgenic animals are genetically modified organisms with DNA from another source inserted into their genome. The document discusses the history of studying genes and developing transgenic techniques. It provides details on how transgenic animals are produced, primarily through DNA microinjection into reproductive cells. A variety of transgenic animals have been created for various purposes, such as developing disease models. While transgenic research has benefits, it also raises ethical issues and animal welfare concerns that require consideration.
The document discusses animal ethics and care in biomedical research. It covers:
1. The importance of animal models in biomedical research due to their biological similarities to humans.
2. A brief history of animal ethics regulations globally and in India, including the establishment of organizations like CPCSEA to oversee animal experimentation.
3. Guidelines from CPCSEA on proper veterinary care, procurement, quarantine, and disease control for animals used in research.
This document discusses animal breeding and selection. It covers several key points:
1) Genetic improvement is the goal of any breeding program and is influenced by both genetics (G) and environment (E).
2) Selection considers the whole population, not just individuals. Tools like EPDs and performance records are used.
3) Traits like growth, reproduction, and longevity should be breeding goals. Methods like individual, family, and progeny testing are used for single or multiple trait selection.
4) Crossbreeding can increase performance through hybrid vigor/heterosis and breed complementarity compared to purebreeding. Organized crossbreeding systems maximize these benefits.
The document provides an overview of the field of biotechnology, including its history, key areas and applications. It discusses topics like genetic engineering, recombinant DNA technology, transgenic plants and animals, DNA microarrays, bioinformatics, and careers in biotechnology. The future prospects of biotechnology in addressing global challenges like food security and healthcare are also highlighted.
Aquaculture is defined as the farming of aquatic organisms such as fish, crustaceans, mollusks, and seaweed. It involves cultivating these organisms in controlled freshwater or saltwater environments. The document discusses the history of aquaculture, commonly cultured species, current global production levels, nutritional and economic benefits, career opportunities, and relevant academic journals. Aquaculture is one of the fastest growing food production systems and accounts for approximately 25% of seafood consumed in the US.
Mushroom Mountain workshop at CFSA. This handout/these slides were presented at the 30th Annual Carolina Farm Stewardship Association by the Author. Please do not reproduce without the express consent of the authors.
Introduction To Biological Products, Biotechnological Products& Their Appli...Zahra Naz
This document provides an overview of biological products and biotechnological products. It begins with an introduction to biological products, which are substances produced by living organisms, such as blood, toxins, vaccines, etc. It then discusses the four main types of biological molecules - carbohydrates, proteins, lipids, and nucleic acids. The document further explains biotechnology as the controlled use of biological agents like microorganisms. Examples of biotechnological products created through recombinant DNA technology are discussed, including antibiotics, vaccines, genetically modified organisms, and transgenic plants. Specific biotechnological products like proteins, antibiotics, vitamins, and their medical applications are also summarized.
This document discusses biotechnology and genetically modified foods. It begins by defining biotechnology and describing how media has portrayed it. It then examines the ethical, legal, and social effects of biotechnology. Several criticisms of genetically modified foods are outlined related to allergens, toxins, and stability. Examples of genetically engineered plant and animal combinations are provided. The document concludes by discussing the debate around using biotechnology to solve world hunger versus potential human and environmental health risks.
This document discusses ethics in animal cloning. It begins by explaining that animal cloning began in 1996 with the cloning of Dolly the sheep. It then discusses why ethics are involved, as cloning produces exact replicas and interferes with nature. Some potential positives of cloning are an endless food supply and ability to clone endangered species. However, some negatives include losing genetic diversity, harming animal welfare, and challenging concepts of nature. The document argues that while benefits to humans are often called ethical, one must consider if cloning is truly necessary or beneficial when it impacts other species. Overall it questions if the risks of cloning outweigh the potential rewards.
This document discusses primary cells and their use in biomedical research. Primary cells are isolated directly from tissues and have important advantages over cell lines, including greater biological relevance. Primary cells are used in applications such as biomarker research, drug development, immunotherapeutics, and tissue engineering. The document reviews techniques for working with primary cells, including isolation, culture, differentiation, and characterization using methods like flow cytometry and immunoassays. Primary cells provide a more physiologically relevant model for research compared to cell lines.
This document discusses plant biopharming, which involves producing recombinant proteins in transgenic plants. It provides an overview of the concept, strategies, production systems, applications and case studies of plant biopharming. Specifically:
1. Plant biopharming is more cost effective than traditional systems, with transgenic plants able to produce proteins on a large scale. Common plants used include tobacco, cereals and potatoes.
2. Stable nuclear transformation is the most common method to generate transgenic plants. Applications include producing monoclonal antibodies, industrial enzymes, and edible vaccines in plants.
3. A case study demonstrates the production of highly concentrated and heat-stable hepatitis B surface antigen in transgenic maize, with the
Peter Singer - Non-Human Animal Ethics - EA Global Melbourne 2015Adam Ford
Peter Singer discusses moral value of non-human animals - the history of moral progress around equality of human animals and how we ought to treat animals - from Judaism & Christianity to Aristotle to Bentham (father of modern utilitarianism). Singer highlights Benthan's view that the capacity for suffering/joy is the vital characteristic that entitles a being to moral consideration. He discusses why we should take non-human animal suffering seriously and what we can do to alleviate the suffering of non-human animals.
Animal Liberation: https://en.wikipedia.org/wiki/Animal_Liberation_%28book%29
Peter paper 'SPECIESISM AND MORAL STATUS' where he convincingly rejects Speciesism: http://www.oswego.edu/~delancey/Singer.pdf
Abstract: "Many people believe that all human life is of equal value. Most of them also believe that all human beings have a moral status superior to that of nonhuman animals. But how are these beliefs to be defended? The mere difference of species cannot in itself determine moral status. The most obvious candidate for regarding human beings as having a higher moral status than animals is the superior cognitive capacity of humans. People with profound mental retardation pose a problem for this set of beliefs, because their cognitive capacities are not superior to those of many animals. I argue that we should drop the belief in the equal value of human life, replacing it with a graduated view that applies to animals as well as to humans."
Plato.Stanford Entry on Moral Status of Animals: http://plato.stanford.edu/entries/moral-animal/
Biography: Peter Singer is Ira W. DeCamp Professor of Bioethics in the University Center for Human Values at Princeton University, a position that he now combines with the position of Laureate Professor at the University of Melbourne. His books include Animal Liberation, Practical Ethics, The Life You Can Save, The Point of View of the Universe and The Most Good You Can Do. In 2014 the Gottlieb Duttweiler Institute ranked him third on its list of Global Thought Leaders, and Time has included him among the world’s 100 most influential people. An Australian, in 2012 he was made a Companion to the Order of Australia, his country’s highest civilian honour.
Video here: https://www.youtube.com/watch?v=TgRoZVT6kYc
This document discusses genetic manipulation and bioethics. It explores the potential pros and cons of genetic engineering, such as using it to cure diseases but also potentially creating a subclass of "enhanced" humans. The purpose is to examine both sides of this issue and promote discussion around the possibilities and ethical implications of genetic science. Some of the pros mentioned are curing diseases like HIV/AIDS and growing new organs, while cons include unknown long-term risks and possible social effects like a subclass of citizens. The document questions where to draw the line with this technology.
Transfection is the process of introduction of foreign DNA into the nucleus of eukaryotic cell. The cells which has incorporated exogenous DNA are called transfectants.
There are two types of Transfection possible,
Transient and
Stable Transfection.
In transient Transfection, the foreign DNA will not get incorporated in to the host genome, but genes are expressed for limited period of time (24-96 hrs).
Stable transfectants will have the foreign DNA incorporated into the genome.
Bioethics associated with transgenic animals.pptxKaurKawaljeet
There are many ethical issues that are needed to be considered while scientifically handling and creating transgenic animals. This presentation the bioethics which are related to the transgenic animals.
The document discusses several ethical issues related to genetic modification of animals including:
1) Safety and health risks for animals and humans from long-term effects and environmental impacts.
2) Questions of who benefits from the technology and whether it is distributed justly.
3) Potential harms to animal welfare from techniques like cloning that have low success rates and risks of health problems.
4) Concerns about impacts on the environment if modified animals escape and their genes spread widely.
5) Need for public understanding and involvement in decisions around applying new biotechnologies.
This document discusses several ethical issues related to genetic modification of animals including animal welfare, risks to human health, distributive justice, and more. It notes concerns about long term effects, environmental impacts, benefits primarily going to large agribusiness, and conflicts of interest with biotech companies. The document argues that new technologies should not be implemented without public understanding and discussion, and that scientists have a responsibility to consider social and ethical implications not just make new discoveries.
The document discusses genetically modified organisms (GMOs) and foods (GMFs) including their techniques, benefits, risks, and perspectives from various religions. It notes that GMFs are typically transgenic plant products that are engineered for traits like pest resistance, vitamin content, or drought tolerance. While offering potential benefits, they may pose environmental or human health risks. Most major scientific organizations say currently available GMOs are safe, but religious views on GMOs vary and are still debated among scholars.
This document discusses ethical issues relating to transgenic animals. It begins by defining transgenesis as the addition of DNA from one organism to another, resulting in creatures that blur species lines. It then discusses various methods for producing transgenic animals, both natural and artificial. It explores applications of transgenic animals like protein production but also problems with low efficiency and health issues in the animals. The document raises ethical concerns about modifying animal genetics without knowing effects, treating animals as commodities, and creating diseased animals. It examines both religious views for and against genetic engineering of animals. Finally, it outlines principles from the 1995 Banner Report regarding the justification and minimization of animal harm in research.
The document discusses the process of genetically engineering animals to produce pharmaceutical drugs. It describes how recombinant DNA from other species is inserted into animals like goats, cows, and chickens to make them produce therapeutic proteins in their milk, blood or eggs. This is presented as a more efficient and less expensive way to manufacture drugs like antithrombin, insulin, lactoferrin and anti-cancer proteins compared to other methods. However, some ethical concerns are raised regarding animal welfare and unintended consequences. The document explores both sides of this complex issue.
Chapter 2- research involving animals .pptxHendmaarof
Researchers use animal models in research to understand human physiology, diseases, and develop new treatments. Animals are used because they share many biological similarities to humans despite differences in appearance. The 3Rs principles of replacement, reduction, and refinement guide researchers to replace animal use when possible, reduce the number of animals used, and refine experiments to minimize animal suffering. While some disagree with animal research, proponents argue it has advanced medical knowledge and led to treatments for conditions like polio, cystic fibrosis, and stroke.
This document provides information about animal biotechnology through several sections. It begins with an introduction that discusses the long history of animal biotechnology including traditional breeding techniques dating back to 5000 BC. It then covers the history of animal biotechnology from the 1970s to the present day, highlighting important milestones. Several sections follow on the scope, applications, and terminology of animal biotechnology including transgenic animals, cloning, animal models in research, vaccines, nutrition, and embryo transfer. The document concludes by defining common terminology used in animal cell culture.
Biotechnology has significantly impacted the livestock industry through advances in animal breeding, cloning, and genetic engineering. However, these practices also face issues. Animal breeding aims to produce hardier livestock but some facilities have abused animals. Cloning creates exact copies of animals but cloned animals often have health problems. Genetic engineering can alter animal traits but modifying animal genes risks unintended health consequences if the meat is consumed by humans. The use of growth hormones and antibiotics in livestock is also controversial as it may impact animal and human health.
This document discusses the topics of genetically modified food and cloning. Regarding genetically modified food, it outlines both potential benefits like increasing yields and drought resistance, as well as risks like unpredictable health effects, gene flow into the environment, and lack of long-term testing. It also discusses challenges around labeling GM foods and commercial interests prioritizing profits over safety. Regarding cloning, it notes past successes cloning animals but also potential difficulties and ethical concerns about cloning humans. Overall it presents both sides of these complex issues around new biotechnologies.
24Etikk i praksis. Nordic Journal of Applied Ethics (2013), 7 .docxeugeniadean34240
24Etikk i praksis. Nordic Journal of Applied Ethics (2013), 7 (1), s.
Introducing the new meat. Problems and
prospects
Stellan Welin
Department of Medical and Health Sciences, Linköping University, Sweden, [email protected]
Cultured meat, or in vitro meat, is one of the ideas that are being proposed to help solve the
problems associated with the ever-growing global meat consumption. The prospect may
bring benefit for the environment, climate, and animal ethics, but has also generated doubts
and criticism. A discussion of the possible environmental benefit and of animal ethics issues
in relation to cultured meat production will be given. A perceived ’unnaturalness’ of cultu-
red meat may be one of the strongest barriers for public acceptance. This will be discussed
and rejected. As to our relations with nature and animals, it is plausible that cultured meat
will lead to improvement rather than to deterioration. The issue of public acceptance and
some of the problems of introducing this new product on the market will also be discussed.
Keywords: cultured meat, naturalness, environment, animal ethics
Introduction
Once upon a time, all meat was obtained from hunting wild animals. This was the first
stage in meat production (Welin et al. 2012). It is still predominant in fisheries, where the
fish still is ’hunted’ by big fleets of fishing ships. There are not too many wild big animals
left for hunting, nor are the stocks of fish what they used to be. Where there is a conside-
rable hunting, like the hunting of moose in Sweden, there is a regulated regime keeping
the stock at an approriate level. In the area of fisheries, problems are more difficult as the
fish moves across national boundaries and on international water. Many of the stocks of
fish around the world have been depleted and are on the brink to collapse.
The second stage in meat production was herding and slaughtering of domesticated
animals. This meant unintentionally that the kind of meat to be eating from farm and
range animals was restricted to the animals human had managed to domesticate. A
similar kind of procedure has taken place in relation to fish, although there is no need to
first domesticate the fish.
The third stage in meat production is about to happen. The idea is to produce meat
(muscle tissue) from animal stem cells with tissue-engineering techniques. A successful
meat production in this way will constitute a radically new way of obtaining meat, namely
without using animals at all.
In this paper, I will discuss the new technology of cultured meat. First I will give a very
short description of some of the technical aspects. After a short overview of the problems
24 – 37
Introducing the new meat. Problems and prospects 25
Stellan Welin
with present day meat production in relation to environment and ethics I turn to the pos-
sible advantages of cultured meat in these aspects.
Two other issues will be discussed relating to ’naturalness’ and our relation wit.
Like all technologies, biotechnology offers the potential of enormous benefit but also potential risks. Biotechnology could help address many global problems, such as climate change, an aging society, food security, energy security and infectious diseases, to name just a few.human health and animal health and welfare and increasing livestock productivity. Biotechnology improves the food we eat - meat, milk and eggs. Biotechnology can improve an animal's impact on the environment. And biotechnology enhances ability to detect, treat and prevent diseases.
This document discusses the debate around the use of animals in scientific research. While animal research has contributed to medical advances and is still used to study diseases, the practice is controversial as some view it as cruel and argue alternative methods now exist. Regulations require minimizing animal use and suffering, but others believe animal lives have intrinsic value beyond just suffering. Toxicology testing on animals makes up a large portion of research, and involves testing products without anesthesia, though classifications are used to assess suffering levels. Proponents argue animal research has been vital to medical advances, while critics call for public inquiries to reconsider its effectiveness and necessity.
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
Nucleophilic Addition of carbonyl compounds.pptxSSR02
Nucleophilic addition is the most important reaction of carbonyls. Not just aldehydes and ketones, but also carboxylic acid derivatives in general.
Carbonyls undergo addition reactions with a large range of nucleophiles.
Comparing the relative basicity of the nucleophile and the product is extremely helpful in determining how reversible the addition reaction is. Reactions with Grignards and hydrides are irreversible. Reactions with weak bases like halides and carboxylates generally don’t happen.
Electronic effects (inductive effects, electron donation) have a large impact on reactivity.
Large groups adjacent to the carbonyl will slow the rate of reaction.
Neutral nucleophiles can also add to carbonyls, although their additions are generally slower and more reversible. Acid catalysis is sometimes employed to increase the rate of addition.
BREEDING METHODS FOR DISEASE RESISTANCE.pptxRASHMI M G
Plant breeding for disease resistance is a strategy to reduce crop losses caused by disease. Plants have an innate immune system that allows them to recognize pathogens and provide resistance. However, breeding for long-lasting resistance often involves combining multiple resistance genes
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
When I was asked to give a companion lecture in support of ‘The Philosophy of Science’ (https://shorturl.at/4pUXz) I decided not to walk through the detail of the many methodologies in order of use. Instead, I chose to employ a long standing, and ongoing, scientific development as an exemplar. And so, I chose the ever evolving story of Thermodynamics as a scientific investigation at its best.
Conducted over a period of >200 years, Thermodynamics R&D, and application, benefitted from the highest levels of professionalism, collaboration, and technical thoroughness. New layers of application, methodology, and practice were made possible by the progressive advance of technology. In turn, this has seen measurement and modelling accuracy continually improved at a micro and macro level.
Perhaps most importantly, Thermodynamics rapidly became a primary tool in the advance of applied science/engineering/technology, spanning micro-tech, to aerospace and cosmology. I can think of no better a story to illustrate the breadth of scientific methodologies and applications at their best.
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...University of Maribor
Slides from talk:
Aleš Zamuda: Remote Sensing and Computational, Evolutionary, Supercomputing, and Intelligent Systems.
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Inter-Society Networking Panel GRSS/MTT-S/CIS Panel Session: Promoting Connection and Cooperation
https://www.etran.rs/2024/en/home-english/
ESPP presentation to EU Waste Water Network, 4th June 2024 “EU policies driving nutrient removal and recycling
and the revised UWWTD (Urban Waste Water Treatment Directive)”
Phenomics assisted breeding in crop improvementIshaGoswami9
As the population is increasing and will reach about 9 billion upto 2050. Also due to climate change, it is difficult to meet the food requirement of such a large population. Facing the challenges presented by resource shortages, climate
change, and increasing global population, crop yield and quality need to be improved in a sustainable way over the coming decades. Genetic improvement by breeding is the best way to increase crop productivity. With the rapid progression of functional
genomics, an increasing number of crop genomes have been sequenced and dozens of genes influencing key agronomic traits have been identified. However, current genome sequence information has not been adequately exploited for understanding
the complex characteristics of multiple gene, owing to a lack of crop phenotypic data. Efficient, automatic, and accurate technologies and platforms that can capture phenotypic data that can
be linked to genomics information for crop improvement at all growth stages have become as important as genotyping. Thus,
high-throughput phenotyping has become the major bottleneck restricting crop breeding. Plant phenomics has been defined as the high-throughput, accurate acquisition and analysis of multi-dimensional phenotypes
during crop growing stages at the organism level, including the cell, tissue, organ, individual plant, plot, and field levels. With the rapid development of novel sensors, imaging technology,
and analysis methods, numerous infrastructure platforms have been developed for phenotyping.
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
3. Biotechnology isn't something new - selective breeding to create
more useful varieties of animals and plants is a form of
biotechnology that human beings have used for thousands of years.
Biotechnology includes any use of science or technology to alter the
characteristics of a particular breed or animal.
Biotechnology can be good or bad for animals - and it may also
produce an answer to the ethical problems of experimenting on
animals. Transgenic animals raise a particularly difficult problem.
4. Human problems :-
Newspaper articles about the ethical problems of genetically engineered
animals are usually concerned about the danger these animals may pose to
human beings (usually to human health), rather than any implications for the
animals themselves.
5. Animal rights :-
Genetic engineering and selective breeding appear to violate animal
rights, because they involve manipulating animals for human ends as if
the animals were nothing more than human property, rather than
treating the animals as being of value in themselves.
Recent action to allow animals to be patented reinforces the idea of
animals as human property, rather than beings in their own right.
6. Animal welfare :-
Biotechnology can be good for animals. Selective breeding and genetic
engineering can benefit animals in many ways:
Improving resistance to disease
Breeding to remove characteristics that cause injury
eg selecting cattle without horns
But biotechnology can also be bad for animals - the good effects for the
breeder can offset by painful side-effects for the animals:
Modern pigs have been bred to grow extra fast - some breeds now grow too
fast for their hearts, causing discomfort when animals are too active
Broiler chickens are bred to grow fast - some now grow too fast for their legs
7. Regulating genetic engineering :-
Profitability is one of the major drivers of both selective breeding and genetic
engineering.
If animal welfare is not to be compromised, research must be restricted by a
counter-balancing ethical principle that prevents altering animals in a way that
was bad for the animal.
One writer, Bernard Rollin, suggests that a suitable rule to regulate genetic
engineering would be this:
Genetically engineered animals should be no worse off than the parent stock
would be if they were not so engineered.
This principle can easily be adapted to cover selective breeding.
8. Biotechnology and experimental animals :-
It's been suggested that genetic engineering may solve all the ethical
problems of laboratory experiments on animals. The goal is to create a
genetically engineered mammal that lacks sentience, but is otherwise
identical to normal experimental animals.
Such an animal could not suffer whatever was done to it, so there should be
no ethical difficulty in performing experiments on it.
9. Transgenic Animal :-
Transgenic animals are animals that have been deliberately bred for
research and that contain elements of two different species - they are
creatures that blur the barrier between species.
These animals are often deliberately created with genetic defects, and
these defects may well cause the animal to have a bad quality of life. A
mouse has been created, for example, that has been genetically
modified to develop cancer.
10. Ethical issues of transgenic animals :-
Transgenic animals raise several particular moral issues :-
Are animals that combine species an unethical alteration of the natural order
of the universe?
Is it unethical to modify an animal's genetic make-up for a specific purpose,
without knowing in advance if there will be any side-effects that will cause
suffering to the animal?
Does 'creating' animals by genetic engineering amount to treat the animals
entirely as commodities?
Is it unethical to create 'diseased' animals that are very likely to suffer?
Suffering may last for a long time in these animals as researchers want to
conduct long-term investigations into the development of diseases
11. Religious views of transgenic animals
Against transgenic animals:-
God laid down the structure of creation and any tampering with it is sinful.
Manipulating DNA is manipulating 'life itself' - and this is tampering with something
that God did not intend humanity to meddle with.
In favour of transgenic animals:
As human beings have been given 'dominion' over the animals, they are entitled to
tamper with them.
Palaeontology shows that the structure of creation has changed over time as some
species became extinct and new ones came into being. They say that this shows that
there is nothing fixed about the structure of creation.
12. Transgenic animals and religious food laws :-
Transgenic animals pose problems for religions that restrict the foods
that their believers can eat, since they may produce animals that
appear to be one species, but contain some elements of a forbidden
species.
13. Major Issues in Biotechnology
Changing the genetic material of
an organism using artificial means
Planting genetically modified
plants
Raising genetically modified
animals
14. Major Issues
• Maintaining genetic diversity in wild plants and
animals
• Taking drugs produced through genetic
modification
• Injecting foreign genes into the human body to
promote good health
15. Religion and Biotech
• Influence biotech 2 different ways:
–Religion set moral rules that will influence
the way a person perceives what is good or
bad
–Common fact that God created life
16. Ethics and the Future of
Biotech• Developments are limited by advancements
in science and by ethical rules.
• Some of the progress are considered
morally unacceptable exp. Cloning